Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
TNDM
TNDM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNDM News
Rosen Law Firm Investigates Securities Claims for Tandem Diabetes Care
Feb 08 2026
Globenewswire
Rosen Law Firm Investigates Tandem Diabetes for Securities Claims
Feb 07 2026
PRnewswire
Rosen Law Firm Investigates Securities Claims for Tandem Diabetes Care
Feb 06 2026
Globenewswire
Analysis of TNDM Put Selling Strategy
Feb 02 2026
NASDAQ.COM
Rosen Law Firm Investigates Tandem Diabetes Securities Claims
Jan 31 2026
PRnewswire
Rosen Law Firm Investigates TNDM Securities Claims
Jan 30 2026
Globenewswire
Rosen Law Firm Investigates Securities Claims for Tandem Diabetes Care
Jan 27 2026
Globenewswire
Rosen Law Firm Investigates Tandem Diabetes Securities Claims
Jan 27 2026
PRnewswire
Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Fraud
Jan 23 2026
Globenewswire
Rosen Law Firm Investigates TNDM Securities Fraud Claims After 19.9% Stock Drop
Jan 22 2026
PRnewswire
Rosen Law Firm Investigates Tandem Diabetes Care for Potential Securities Fraud
Jan 20 2026
Globenewswire
Rosen Law Firm Investigates Tandem Diabetes Care Securities Fraud Claims
Jan 18 2026
Globenewswire
Rosen Law Firm Investigates TNDM Securities Fraud Claims
Jan 17 2026
PRnewswire
Avant Technologies Achieves 83% Insulin Independence Rate, Driving Investment Shift
Dec 31 2025
PRnewswire
Avant Technologies Achieves 83% Insulin Independence Rate, Driving Metabolic Disease Investment
Dec 31 2025
Newsfilter
Rosen Law Firm Investigates Potential Securities Claims for Tandem Diabetes Care, Inc.
Dec 31 2025
PRnewswire
Show More News
